ヒト (JP Patent Analysis Report)
The Technical Field "ヒト" had 1,344 patent application filings in the most recent period (2022-01-01 to 2022-07-31). This is a significantly decreased of -1,173 filings (-46.6%) over 2,517 they had in the same period of the previous year (2021-01-01 to 2021-07-31). This report also includes technical terms related to " 人類 ", " ホモ・サピエンス(ヒト) ", " ホモサピエンス ", " ホモ・サピエンス " in the search set.
The highest number of filings in 2016 with 5,597 cases, and their lowest number in 2022 with 1,447 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 19,975 cases in total) is 3,329, and the median is 4,121. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 3,329 patents |
| Std Dev | 1,901 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1,447 cases | -64.9 % |
| 2021 year | 4,117 cases | -0.19 % |
| 2020 year | 4,125 cases | -15.70 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ヒト for the period of the last 10 years (2014-01-01 to 2024-03-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ヒト, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
ヒト, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of ヒト over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 40,843 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
ヒト
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "ヒト".
- ヒト (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ヒト are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 15 cases, followed by ジェネンテックインコーポレイテッド with 14 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 15 cases |
| ジェネンテックインコーポレイテッド | 14 cases |
| エフホフマン-ラロシュアーゲー | 13 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
| ノバルティスアーゲー | 7 cases |
| 武田薬品工業株式会社 | 5 cases |
| 中外製薬株式会社 | 2 cases |
| ロレアル | 1 cases |
| アメリカ合衆国 | 1 cases |
| 国立研究開発法人科学技術振興機構 | 1 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 565 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 505 cases.
| Name | Cases |
|---|---|
| ジェネンテックインコーポレイテッド | 565 cases |
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 505 cases |
| ノバルティスアーゲー | 461 cases |
| エフホフマン-ラロシュアーゲー | 367 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 351 cases |
| 中外製薬株式会社 | 150 cases |
| 武田薬品工業株式会社 | 136 cases |
| ロレアル | 112 cases |
| アメリカ合衆国 | 111 cases |
| 国立研究開発法人科学技術振興機構 | 19 cases |
| グラクソグループリミテッド | 16 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ヒト are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 15 cases, followed by ジェネンテックインコーポレイテッド with 14 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 15 cases |
| ジェネンテックインコーポレイテッド | 14 cases |
| エフホフマン-ラロシュアーゲー | 13 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 12 cases |
| ノバルティスアーゲー | 7 cases |
| ロレアル | 1 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last for the target period (2014 to 2024) with 565 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 505 cases.
| Name | Cases |
|---|---|
| ジェネンテックインコーポレイテッド | 565 cases |
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 505 cases |
| ノバルティスアーゲー | 461 cases |
| エフホフマン-ラロシュアーゲー | 367 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 351 cases |
| ロレアル | 112 cases |
| グラクソグループリミテッド | 16 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by ヒト’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by ヒト’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
ヒト filed 565 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 190 cases in total) is 31.7, and the median is 37.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 118 cases, and their lowest number in 2022 with 14 cases.
| Index | Value |
|---|---|
| Average | 31.7 patents |
| Std Dev | 19.4 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 14 cases | -67.4 % |
| 2021 year | 43 cases | +13.16 % |
| 2020 year | 38 cases | +5.56 % |
Trends in filing of joint patent applications with ノバルティスアーゲー
ヒト filed 461 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 161 cases in total) is 26.8, and the median is 23.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 89 cases, and their lowest number in 2022 with 7 cases.
| Index | Value |
|---|---|
| Average | 26.8 patents |
| Std Dev | 21.2 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 7 cases | -69.6 % |
| 2021 year | 23 cases | -4.17 % |
| 2020 year | 24 cases | -46.7 % |
Trends in filing of joint patent applications with ロレアル
ヒト filed 112 joint applications with ロレアル for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 50 cases in total) is 8.3, and the median is 9.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2018 with 21 cases, and their lowest number in 2022 with 1 cases.
| Index | Value |
|---|---|
| Average | 8.3 patents |
| Std Dev | 6.9 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1 cases | -90.0 % |
| 2021 year | 10 cases | 0 |
| 2020 year | 10 cases | +25.00 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
ヒト filed 367 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 161 cases in total) is 26.8, and the median is 27.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 67 cases, and their lowest number in 2022 with 13 cases.
| Index | Value |
|---|---|
| Average | 26.8 patents |
| Std Dev | 18.0 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 13 cases | -35.0 % |
| 2021 year | 20 cases | -47.4 % |
| 2020 year | 38 cases | -30.9 % |
Trends in filing of joint patent applications with ザリージェンツオブザユニバーシティオブカリフォルニア
ヒト filed 351 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 186 cases in total) is 31.0, and the median is 39.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 55 cases, and their lowest number in 2022 with 12 cases.
| Index | Value |
|---|---|
| Average | 31.0 patents |
| Std Dev | 18.9 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 12 cases | -67.6 % |
| 2021 year | 37 cases | -9.76 % |
| 2020 year | 41 cases | 0 |
Information on important patents (JP)
The following shows JP patents held by ヒト that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and ヒト’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which ヒト is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.1 times. The most recently Invalidation Trial patent is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 3 | 特許6914336 | 進行したＨＥＲ２発現がんの治療 | 2022-11-15 |
| 4 | 特許6773929 | 細胞傷害誘導治療剤 | 2022-03-31 |
| 5 | 特許6692856 | ＲＮＡ依存性標的ＤＮＡ修飾およびＲＮＡ依存性転写調節のための方法および組成物 | 2022-02-25 |
| 6 | 特許4001199 | ヒドロピリジン誘導体酸付加塩 | 2022-02-22 |
| 7 | 特許6738314 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2021-07-02 |
| 8 | 特許5460866 | 敗血症の質量分析法診断 | 2021-04-13 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 14 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.1. The most invalidation trial patent is 特許5906333 "プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質" (2 times) , and the next most invalidation trial patent is 特許6198346 "１回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤" (2 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許5906333 | プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質 | 2 times |
| 2 | 特許6198346 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 2 times |
| 3 | 特許5910698 | リセドロネート組成物およびその使用方法 | 1 times |
| 4 | 特許6335326 | コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用 | 1 times |
| 5 | 特許6150846 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 34 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7301332 "ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット" (Opposition day 2024-01-04) , next is 特許7298844 "細胞培養物の製造方法" (Opposition day 2023-12-26) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7301332 | ＤＮＡが編集された真核細胞を製造する方法、および当該方法に用いられるキット | 2024-01-04 |
| 2 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 3 | 特許7275044 | 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品 | 2023-11-17 |
| 4 | 特許7262385 | 心筋細胞の成熟 | 2023-10-18 |
| 5 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 6 | 特許7240675 | オトフェルリンを発現させるための組成物および方法 | 2023-09-19 |
| 7 | 特許7222347 | 可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩 | 2023-08-11 |
| 8 | 特許7210036 | アルツハイマー病および他の神経変性障害のためのバイオマーカーおよび診断方法 | 2023-07-20 |
| 9 | 特許7188087 | 一本鎖オリゴヌクレオチド | 2023-06-12 |
| 10 | 特許7093669 | 即効型インスリン組成物 | 2022-12-28 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 99 patents Protest from third parties. The average number of Protest is 1.3 times. The most recently Protest patent is 特開2022-186756 "アルロース結晶の製造方法" (Protest day 2024-03-20) , next is 特開2023-175938 "糖代謝改善用組成物" (Protest day 2024-03-04) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2022-186756 | アルロース結晶の製造方法 | 2024-03-20 |
| 2 | 特開2023-175938 | 糖代謝改善用組成物 | 2024-03-04 |
| 3 | 特表2023-525856 | ＡＴＩ消化のための方法及び組成物 | 2024-02-28 |
| 4 | 特開2023-052694 | 悪臭調節化合物の同定方法 | 2024-02-17 |
| 5 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-02-16 |
| 6 | 特開2023-184766 | 錠剤及び錠剤の製造方法 | 2024-02-13 |
| 7 | 特表2023-534047 | オリゴ糖組成物及び使用方法 | 2024-02-07 |
| 8 | 特表2023-544184 | 接着細胞からのウイルスのバイオリアクター生成 | 2024-02-01 |
| 9 | 特表2022-504702 | 緩衝塩及びアミノ酸を含有する粉末、そのような粉末の栄養製品への再構成、並びにそのような栄養製品を使用する方法 | 2024-01-30 |
| 10 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-23 |
| 11 | 特開2021-116296 | コロナウイルス感染の治療におけるファビピラビルの使用 | 2023-12-19 |
| 12 | 再公表2019/240288 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 | 2023-11-29 |
| 13 | 特表2023-512475 | 三環式ＰＤＥ３／ＰＤＥ４二重阻害剤化合物の医薬組成物 | 2023-11-28 |
| 14 | 特表2021-522205 | 敗血症および敗血症性ショックの治療 | 2023-11-06 |
| 15 | 特開2021-172633 | 表皮バリア機能改善剤 | 2023-11-01 |
| 16 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 2023-10-30 |
| 17 | 特表2022-542401 | 光硬化性組成物をベースとするネイルコーティング | 2023-10-23 |
| 18 | 特開2022-001555 | ヒトノロウイルス不活化剤 | 2023-10-06 |
| 19 | 特開2022-130629 | ベンダムスチンの製剤 | 2023-09-29 |
| 20 | 特開2022-141895 | ベンダムスチンの製剤 | 2023-09-29 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 189 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特許7316626 "カリシウイルス科ウイルス不活性化剤組成物及び衛生資材" (5 times) , and the next most protest patent is 特許7390695 "錠剤及び錠剤の製造方法" (5 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7316626 | カリシウイルス科ウイルス不活性化剤組成物及び衛生資材 | 5 times |
| 2 | 特許7390695 | 錠剤及び錠剤の製造方法 | 5 times |
| 3 | 特開2021-116296 | コロナウイルス感染の治療におけるファビピラビルの使用 | 4 times |
| 4 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 4 times |
| 5 | 特表2016-517860 | 頻脈性不整脈の長期治療における塩酸ランジオロールの使用 | 3 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 802 patents Inspection from third parties. The average number of Inspection is 1.5 times. The most recently Inspection patent is 特表2021-505168 "操作されたＴ細胞の組成物を製造するための方法" (Inspection day 2024-03-26) , next is 特開2022-104994 "細胞培養のための細胞外マトリクス組成物ビーズ" (Inspection day 2024-03-26) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2021-505168 | 操作されたＴ細胞の組成物を製造するための方法 | 2024-03-26 |
| 2 | 特開2022-104994 | 細胞培養のための細胞外マトリクス組成物ビーズ | 2024-03-26 |
| 3 | 特開2019-011372 | インターロイキン−６関連疾患の治療方法 | 2024-03-26 |
| 4 | 特許6907394 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 5 | 特開2021-105999 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 6 | 特許7212226 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 7 | 特許6840887 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 8 | 特許6889338 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 9 | 特許7064641 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 10 | 特開2022-115880 | ペットフードレコメンド装置および、ペットフードレコメンド方法、サプリメントレコメンド装置、サプリメントレコメンド方法ならびに腸年齢算出式決定方法および腸年齢算出方法 | 2024-03-22 |
| 11 | 特表2020-506708 | ＣＯ２および他のＣ１基質の、ビーガン栄養素、肥料、バイオスティミュラント、および土壌炭素隔離の加速のためのシステムへの微生物変換 | 2024-03-19 |
| 12 | 特表2021-516049 | 組換えＴ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
| 13 | 特許5448133 | 香料組成物 | 2024-03-15 |
| 14 | 特表2021-529821 | イムノグロブリンを除去又は減少させるための遺伝子治療ベクターの形質導入を増加または増強するための組成物および方法 | 2024-03-13 |
| 15 | 特表2021-534146 | アセチル−ＣＯＡカルボキシラーゼ２アンチセンスオリゴヌクレオチド | 2024-03-12 |
| 16 | 特開2023-175938 | 糖代謝改善用組成物 | 2024-03-11 |
| 17 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-03-11 |
| 18 | 特開2022-105066 | がん免疫療法の臨床効果を予測する免疫学的バイオマーカー | 2024-02-27 |
| 19 | 特開2022-081543 | 抗ＴＲＥＭ２抗体及びその使用方法 | 2024-02-27 |
| 20 | 特表2021-531276 | 完全ヒトグリコシル化ヒトα−Ｌ−イズロニダーゼ（ＩＤＵＡ）を用いたムコ多糖症Ｉ型の治療 | 2024-02-22 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 1,496 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.4. The most inspection patent is 特許6320473 "アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング" (48 times) , and the next most inspection patent is 特開2017-149726 "Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6320473 | アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング | 48 times |
| 2 | 特開2017-149726 | Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
| 3 | 特許6198346 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 18 times |
| 4 | 特許6150846 | １回当たり１００〜２００単位のＰＴＨが週１回投与されることを特徴とする、ＰＴＨ含有骨粗鬆症治療／予防剤 | 15 times |
| 5 | 特許6025881 | 高純度ＰＴＨ含有凍結乾燥製剤およびその製造方法 | 13 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 5,629 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.2. The most cited patent is 特許6232009 "ＣＤＲのアミノ酸置換により抗体の等電点を改変する方法" (37 times) , and the next most cited patent is 特表2016-521975 "遺伝的状態の処置のための方法および組成物" (34 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6232009 | ＣＤＲのアミノ酸置換により抗体の等電点を改変する方法 | 37 times |
| 2 | 特表2016-521975 | 遺伝的状態の処置のための方法および組成物 | 34 times |
| 3 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 33 times |
| 4 | 特許6688562 | エネルギを回生する歩行ロボットシステム | 30 times |
| 5 | 特許6738729 | 分裂終了細胞の疾患および障害をターゲティングおよびモデリングするための系、方法および組成物の送達、エンジニアリングおよび最適化 | 28 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.